Aurora Spine Corporation
ASAPF
$0.23
$0.00492.18%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.34% | 20.95% | 20.01% | 16.70% | 9.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.34% | 20.95% | 20.01% | 16.70% | 9.05% |
| Cost of Revenue | 13.18% | 9.82% | 5.54% | -0.85% | -6.41% |
| Gross Profit | 16.86% | 29.51% | 31.87% | 32.17% | 23.28% |
| SG&A Expenses | 19.53% | 26.86% | 20.31% | 22.01% | 17.96% |
| Depreciation & Amortization | -13.12% | -3.98% | -5.32% | 10.46% | 19.90% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.11% | 13.87% | 7.98% | 7.70% | 4.84% |
| Operating Income | 33.88% | 54.94% | 77.05% | 58.69% | 32.30% |
| Income Before Tax | 15.50% | 40.34% | 71.56% | 54.48% | 27.75% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 15.50% | 40.34% | 71.56% | 54.48% | 27.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.50% | 40.34% | 71.56% | 54.48% | 27.75% |
| EBIT | 33.88% | 54.94% | 77.05% | 58.69% | 32.30% |
| EBITDA | 63.09% | 97.92% | 120.21% | 99.66% | 69.92% |
| EPS Basic | 21.35% | 46.25% | 74.62% | 58.44% | 32.06% |
| Normalized Basic EPS | 34.51% | 54.97% | 74.76% | 58.25% | 31.52% |
| EPS Diluted | 21.35% | 46.25% | 74.62% | 58.44% | 32.06% |
| Normalized Diluted EPS | 34.51% | 54.97% | 74.76% | 58.25% | 31.52% |
| Average Basic Shares Outstanding | 6.81% | 9.96% | 12.42% | 10.30% | 8.09% |
| Average Diluted Shares Outstanding | 6.81% | 9.96% | 12.42% | 10.30% | 8.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |